Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: 201104047 Principal Investigator: Thaker, Premal
Title: Feasibility Study: Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients
Description: This research is looking at the effect of biobehavioral factors such as stress and whether these factors alter how the body responds to chemotherapy. One of the purposes of this study is to determine if the addition of a beta-blocker such as Propranolol (Inderal) is tolerable when given with chemot...MORE
___________________________________________________________________________________________________
 Number: GOG 9924 Principal Investigator: Mutch, David
Title: A Phase I Pharmacokinetic Study of Intraperitoneal CTEP-Supplied Agent Bortezomib and Carboplatin in Patients with Persistent or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Description: The purpose of this study is to see what dose of the anti-cancer drug bortezomib can be given with carboplatin in the treatment of your cancer. We will check this by giving this drug and carboplatin, another anti-cancer drug, directly into your abdomen. One of the goals of this study is to determi...MORE
___________________________________________________________________________________________________
 Number: GOG 9923 Principal Investigator: Mutch, David
Title: A Phase I Study of Carboplatin/Paclitaxel/CTEP-Supplied Agent Bevacizumab and CTEP-Supplied Agent ABT-888 in Newly Diagnosed Patients with Previously Untreated Eipthelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Description: One of the purposes of this study is to test the safety of ABT-888 at different dose levels. It will be given with standard initial chemotherapy as well as a drug called bevacizumab. Standard chemotherapy for your type of cancer usually consists of two drugs called carboplatin and paclitaxel. Ano...MORE
___________________________________________________________________________________________________
 Number: GOG 264 Principal Investigator: Mutch, David
Title: A Randomized Phase II Trial of Paclitaxel and Carboplatin vs. Bleomycin Etoposide, and Cisplatin for Newly Diagnosed Advanced Stage and Recurrent Chemonaive Sex Cord-Stromal Tumors of the Ovary
Description: The purpose of this study is to find out whether treatment with drugs paclitaxel and carboplatin work better to control your cancer than treatment with the drugs bleomycin, etoposide and cisplatin, which is the standard treatment for your type of cancer. Another purpose of this study is to find out...MORE
___________________________________________________________________________________________________
 Number: GOG 0260 Principal Investigator: Mutch, David
Title: A Phase II Evaluation of Elesclomol Sodium and Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Description: You are being asked to take part in this study because you have ovarian, fallopian tube, or primary peritoneal cancer that has failed to respond to initial chemotherapies given to you or has re-grown after surgery, radiation therapy, or other forms of therapy. The purpose of this study is to find o...MORE
___________________________________________________________________________________________________
 Number: 201206062 Principal Investigator: Mutch, David
Title: A Randomized, Double Blind, Placebo-Controlled Phase 1b/2 Study of LY2228820, a p38 MAPK Inhibitor, plus Gemcitabine and Carboplatin versus Gemcitabine and Carboplatin for Women with Platinum-Sensitive Ovarian Cancer (Ver 1/11/12)
Description: This study is being done to see how safe an investigational drug (LY2228820) is and how well it will work to help people with ovarian cancer, fallopian tube cancer or primary peritoneal cancer....MORE
___________________________________________________________________________________________________
 Number: 201105400 Principal Investigator: Mutch, David
Title: Formation of a Tissue Bank for Gynecologic Malignancies
Description: The purpose of this study is to collect specimens (i.e., tissue obtained during surgery and/or blood) and related information from women who are undergoing surgery for a gynecologic condition. Specimens and related information that are collected for this research study will be used for future cance...MORE
___________________________________________________________________________________________________
 Number: 201104242 Principal Investigator: Thaker, Premal
Title: Biobehavioral Influences and the Ovarian Tumor Microenvironment
Description: The purpose of this study is to understand relationships between behavioral factors, hormones, and chemicals produced by the body that may help tumor growth in ovarian cancer. The significance of this research is that it may help in our understanding of risk factors for progression of ovarian cance...MORE
___________________________________________________________________________________________________
 Number: 201209132 Principal Investigator: Garg, Gunjal
Title: Effect of Hormonal Treatment on Outcomes in Women with Ovarian Borderline Tumors
___________________________________________________________________________________________________
 Number: P2C MC0845 Principal Investigator: Picus, Joel
Title: A Phase II Trial of Temsirolimus and Bevacizumab in Patients with Endometrial, Ovarian, Hepatocellular Carcinoma, Carcinoid, or Islet Cell Cancer
Description: This study is being done to learn what effects (good and bad) the combination of temsirolimus and bevacizumab has on you and your cancer. The combination of these two drugs is currently being tested in patients with kidney cancer through another study. Although preliminary results from this study ar...MORE
___________________________________________________________________________________________________